Glaukos Corp. (GKOS)
163.75
+0.58
(+0.36%)
USD |
NYSE |
Oct 02, 16:00
163.76
+0.02
(+0.01%)
Pre-Market: 20:00
Glaukos Net Income (Quarterly) : -18.38M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -18.38M |
| March 31, 2026 | -19.78M |
| December 31, 2025 | -133.66M |
| September 30, 2025 | -16.23M |
| June 30, 2025 | -19.66M |
| March 31, 2025 | -18.15M |
| December 31, 2024 | -33.58M |
| September 30, 2024 | -21.41M |
| June 30, 2024 | -50.54M |
| March 31, 2024 | -40.84M |
| December 31, 2023 | -36.78M |
| September 30, 2023 | -30.44M |
| June 30, 2023 | -32.81M |
| March 31, 2023 | -34.63M |
| December 31, 2022 | -31.46M |
| September 30, 2022 | -27.58M |
| June 30, 2022 | -45.54M |
| March 31, 2022 | 5.377M |
| December 31, 2021 | -21.87M |
| September 30, 2021 | 6.23M |
| June 30, 2021 | -17.48M |
| March 31, 2021 | -16.47M |
| December 31, 2020 | -10.65M |
| September 30, 2020 | -15.75M |
| Date | Value |
|---|---|
| June 30, 2020 | -39.89M |
| March 31, 2020 | -54.06M |
| December 31, 2019 | 36.58M |
| September 30, 2019 | -13.51M |
| June 30, 2019 | -6.309M |
| March 31, 2019 | -1.342M |
| December 31, 2018 | 1.779M |
| September 30, 2018 | -6.621M |
| June 30, 2018 | -5.398M |
| March 31, 2018 | -2.711M |
| December 31, 2017 | 1.006M |
| September 30, 2017 | 1.325M |
| June 30, 2017 | -3.301M |
| March 31, 2017 | 0.878M |
| December 31, 2016 | 0.134M |
| September 30, 2016 | 1.159M |
| June 30, 2016 | 2.332M |
| March 31, 2016 | 0.897M |
| December 31, 2015 | -2.29M |
| September 30, 2015 | -2.057M |
| June 30, 2015 | -32.51M |
| March 31, 2015 | -1.462M |
| March 31, 2014 | -4.339M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Globus Medical, Inc. | 151.57M |
| Abbott Laboratories | 928.00M |
| Alphatec Holdings, Inc. | -25.78M |
| Artivion, Inc. | -13.49M |
| Insulet Corp. | 95.00M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 185.61M |
| Total Expenses (Quarterly) | 203.99M |
| EPS Diluted (Quarterly) | -0.3124 |
| Enterprise Value | 9.455B |
| Gross Profit Margin (Quarterly) | 81.67% |
| Profit Margin (Quarterly) | -9.90% |
| Earnings Yield | -1.99% |
| Normalized Earnings Yield | -1.141 |